For research use only. Not for therapeutic Use.
Tivanisiran sodium is a siRNA used for the study of dry eye disease. Tivanisiran sodium was designed to silence transient receptor potential vanilloid 1 (TRPV1) mRNA[1].
Catalog Number | I040023 |
CAS Number | 1848239-71-3 |
Molecular Formula | C361H411N141O262Na36P36 |
Purity | ≥95% |
Reference | [1]. Anne-Marie Bleau, et al. Development of tivanisiran, a topical siRNA designed to [2]. Javier Moreno-Montañés, et al. Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opin Investig Drugs. 2018 Apr;27(4):421-426. |